National Lung Cancer Working Group

The National Lung Cancer Working Group (NLCWG) provides advice to the Ministry on early detection, diagnosis and treatment of lung cancer and supports the development of improvement initiatives that will improve outcomes for people with lung cancer.

Its role is to:

  • promote the early diagnosis of lung cancer
  • ensure the care provided to people diagnosed with lung cancer is accessible and carried out in a timely way
  • ensure that all people with lung cancer receive quality treatment options
  • actively support Smokefree 2025 vision recognising smoking is the greatest risk factor for lung cancer.

Purpose

To promote a nationally co-ordinated and consistent approach to the prevention, early detection and delivery of care for all people with primary thoracic malignancy, and promoting equitable, timely, quality care.

Its advice covers:

  • the development of lung cancer specific patient management frameworks to guide and promote standards of care across New Zealand for people with lung cancer in primary, secondary and tertiary care
  • the development of national standards of care, guidelines, referral pathways and prioritisation criteria
  • the development of quality performance indicators of service delivery and clinical outcomes
  • appropriate national minimum datasets and quality measures of service delivery and clinical outcomes
  • systemic barriers and equity gap in services and ways to resolve these
  • new developments that may impact on lung cancer outcomes
  • initiatives related to lung cancer that inform the national cancer prioritisation process
  • lung cancer research and appropriate directions for research in the New Zealand context.

Current priorities

  • developing quality performance indicators (QPIs) for lung cancer
  • revising the Standards of Service Provision for Lung Cancer Patients in New Zealand updated in 2016
  • supporting the implementation of the National Early Detection of Lung Cancer Guidance
  • finalising and supporting implementation of the National Guidance - follow up and supportive care of people with lung cancer after curative intent therapy
  • reviewing lung cancer screening research findings as they are published.

In this section

Back to top